Funding for this research was provided by:
Spero Therapeutics (NA)
Received: 30 October 2019
Accepted: 26 January 2021
First Online: 8 February 2021
Ethics approval and consent to participate
: Because this study used already existing fully de-identified data, it was exempt from ethics review under US 45 CFR 46.101(b)4 [CitationRef removed].
: Not applicable.
: UnorderedList removed